Menú
ABOUT US
We are a clinical diagnostics company focused on Alzheimer’s Disease. We will enter the initial markets during 2024. We have developed an innovative saliva-based test as an aid in the diagnosis of Alzheimer’s disease and Mild Cognitive Impairment associated with Alzheimer’s Disease
- The clinical utility of our diagnostic test has been validated by recognized research institutions.
- We have a solid intellectual property position in key markets for the use of Lactoferrin levels in the diagnosis of Alzheimer's disease
Meet our executive team
Juan Carlos del Castillo
Co-founder, CEO and CFO
Juan Carlos is an entrepreneurial executive with 25 years of experience managing and leading major research centres and innovative private companies in virtually all fields of biotechnology. Since stepping down as director of Spain's National Center for Biotechnology in 1999, Juan Carlos has served as CEO of the Genetrix Group, a leading biotechnology holding company in Spain.
Gorka Orive, PhD
Co-founder and CSO
Gorka holds a bachelor’s degree in pharmacy and a PhD from the University of the Basque Country (Vitoria, Spain). He is an Associate Professor of Pharmacy at the University of the Basque Country. Gorka serves as an advisor to the Singapore Eye Research Institute (Singapore) and is an active scientist at the Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN). He has received several awards for excellence in science and has served as an advisor to various companies.
Eva Carro, PhD
Co-Founder and External Scientific Advisor
Lead of the Neurobiology of Alzheimer’s disease laboratory at the Functional Unit for Research into Chronic Disease of Instituto de Salud Carlos III and Research Networking Center in Neurodegenerative Diseases (CIBERNED). PhD in Biology from the Santiago de Compostela University, Spain. She completed several postdoctoral stays including Instituto Cajal-CSIC, Madrid (Spain), Reed Neurology Center, UCLA, LA (USA), Institute Pasteur, Paris (France), and Hospital 12 de Octubre Research Institute, Madrid (Spain). She brings more than 20 years of experience in neurology research in the field of Alzheimer’s disease and other neurodegenerative diseases.
Mel Pinheiro, MBA
Business Development Director
Mel has over 25 years of experience in various roles including Business Development, Project Management, Product Development, Strategic Marketing, and Communication, covering sectors such as the automotive sector, pharmaceuticals, and in vitro diagnostics. She is trilingual (Spanish, English, and Portuguese) and has extensive international experience, particularly in the European and Latin American markets.
oUR PARTNERS
THE GREAT POTENTIAL OF GEROADX
MAKES IT AN EXCELLENT OPTION
FOR INVESTORS.
Contact us if you are interested in investing
Help Center
- FAQs
- Contact
Legal Information
- Terms and Conditions
- Data Protection
- Contact us
Contact
- [email protected]
- Avda. Budapest, 50 01003 Vitoria-Gasteiz (Álava) SPAIN
Copyright © GEROADX
Implementado por www.tango.red